We demonstrated previously that Ptac2S activates the MAPKs signalling pathways in several tumour cell lines [6, 8, 9, 22], ZL55 cells included [12] and that cisplatin activates ERK1/2 in ZL55 cells [15]. The gene discussed is MAPK3; the disease is neoplasm.